GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kubota Pharmaceutical Holdings Co Ltd (TSE:4596) » Definitions » Valuation Rank

Kubota Pharmaceutical Holdings Co (TSE:4596) Valuation Rank


View and export this data going back to 2016. Start your Free Trial

What is Kubota Pharmaceutical Holdings Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Kubota Pharmaceutical Holdings Co Valuation Rank Related Terms

Thank you for viewing the detailed overview of Kubota Pharmaceutical Holdings Co's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Kubota Pharmaceutical Holdings Co (TSE:4596) Business Description

Traded in Other Exchanges
N/A
Address
3-7-1 Kasumigaseki, 4th Floor,Kasumigaseki Tokyu Building, Chiyoda-ku, Tokyo, JPN, 150-6018
Kubota Pharmaceutical Holdings Co Ltd is a Japanese company providing portfolio of drugs and devices to preserve and restore millions of people. It identifies and develops therapeutics to treat the opthalmic disorder and operations incidental or related thereto. Its pipeline products include VCM-Emixustat HCI, Lanosterol and Optogenetics.